Is bone marrow edema syndrome a precursor of hip or knee osteonecrosis? Results of 49 patients and review of the literature.


Journal

Diagnostic and interventional radiology (Ankara, Turkey)
ISSN: 1305-3612
Titre abrégé: Diagn Interv Radiol
Pays: Turkey
ID NLM: 101241152

Informations de publication

Date de publication:
Jul 2020
Historique:
pubmed: 20 6 2020
medline: 27 4 2021
entrez: 20 6 2020
Statut: ppublish

Résumé

Diagnosis of bone marrow edema syndrome (BMES) can be challenging. There is sometimes uncertainty about the correct diagnosis of BMES on morphologic magnetic resonance imaging (MRI), since subchondral findings like lines and spots can be misinterpreted as "beginning" or "possible" avascular osteonecrosis (AVN). The aim of our study was to systematically assess the temporal course of BMES from first diagnosis on MRI until the end of clinical symptoms and the full disappearance of bone marrow edema (BME) to determine whether subchondral lines and spots detected in these patients can develop into osteonecrosis. In a combined retrospective and prospective study, we retrieved serial MRI scans of hips and knees with BME from the hospital database. According to clinical and imaging data, all patients with degenerative, infectious/inflammatory, rheumatic, neoplastic conditions and those showing typical osteonecrosis were excluded. We collected all available MRI examinations from first detection of BME until its disappearance. In case edema had not fully resolved in the last available MRI scan, we performed an MRI with an additional dynamic contrast-enhanced (DCE-MRI) sequence. For each MRI scan, we recorded the severity of edema, the presence of subchondral hypointense lines and the presence of subchondral focal hypointense zones on T1-weighted images by two independent readers. The DCE-MRI scans were used to calculate parameter maps to assess the perfusion characteristics. The study comprised 49 patients aged 22-71 years. In total, 171 morphologic and 5 DCE-MRI scans were evaluated. In 44 patients (89.8%), the BMES completely healed without remnants. In 18 of 49 patients (36.7%), a subchondral line was present in the first MRI exam. Nine patients (18.4%) developed a subchondral line within 1-5 months after the first MRI. In total, 27 out of 49 patients (55.1%) had subchondral lines (12 knees, 15 hips) during the timeframe of the study. All subchondral lines disappeared in the timeframe of the study. Subchondral focal hypointense zones were present in 14 out of 49 patients (28.6%): in 9 cases, subchondral focal hypointense zones disappeared after a median of 5.5 months (range, 1-85 months), while in 5 cases, subchondral focal lesions persisted until the end of the study (up to more than 85 months) without edema in the surrounding bone. All persisting subchondral focal lesions were hyperperfused. These 5 patients had associated meniscal lesions. Our study shows that subchondral lines and spots found in patients with BMES do not develop into AVN. Subchondral lines, which resemble subchondral insufficiency fractures, are associated with BMES. Subchondral focal T1-hypointense zones do not represent AVN; most probably these areas represent reparative processes within the subchondral bone, where tensile and shear force overload is present due to altered biomechanics.

Identifiants

pubmed: 32558648
doi: 10.5152/dir.2020.19188
pmc: PMC7360071
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

355-362

Références

Eur J Radiol. 2014 Oct;83(10):1862-9
pubmed: 25129825
Radiographics. 2010 Jan;30(1):143-63; discussion 163-5
pubmed: 20083591
Magn Reson Imaging. 2001 Sep;19(7):985-91
pubmed: 11595370
Eur J Radiol. 2015 Mar;84(3):431-436
pubmed: 25533717
Orthop Clin North Am. 2004 Jul;35(3):321-33, ix
pubmed: 15271540
Eur J Radiol. 2004 Jun;50(3):238-44
pubmed: 15145483
Arch Orthop Trauma Surg. 2012 Dec;132(12):1781-8
pubmed: 23053191
Radiology. 2017 May;283(2):478-485
pubmed: 27905865
Osteoarthritis Cartilage. 2009 Jun;17(6):743-7
pubmed: 19097919
AJR Am J Roentgenol. 2010 Jul;195(1):W63-8
pubmed: 20566783
Radiology. 1999 Aug;212(2):527-35
pubmed: 10429713
Clin Orthop Surg. 2012 Sep;4(3):173-80
pubmed: 22949947
Eur J Radiol. 2008 Jul;67(1):34-41
pubmed: 18353586
Rheumatology (Oxford). 2014 May;53(5):785-92
pubmed: 24080251
Clin Radiol. 2004 Dec;59(12):1079-93
pubmed: 15556590
Magn Reson Imaging. 1997;15(9):1017-23
pubmed: 9364947
Eur Radiol. 2014 Sep;24(9):2271-8
pubmed: 24863885
J Bone Joint Surg Am. 1995 Apr;77(4):616-24
pubmed: 7713981
Eur J Radiol. 2009 Sep;71(3):398-405
pubmed: 19700255
Ann Rheum Dis. 2010 Oct;69(10):1796-802
pubmed: 20421344
Phys Med Biol. 2007 Jan 21;52(2):429-47
pubmed: 17202625
Radiology. 1989 Apr;171(1):135-40
pubmed: 2928517
Radiology. 1987 Mar;162(3):709-15
pubmed: 3809484
Eur Radiol. 2016 Jun;26(6):1929-41
pubmed: 26334506
Radiology. 1994 May;191(2):403-7
pubmed: 8153313
J Bone Joint Surg Am. 2000 Jun;82(6):858-66
pubmed: 10859106
Eur J Radiol. 2008 Jul;67(1):22-33
pubmed: 18342472
Osteoarthritis Cartilage. 2012 Jan;20(1):13-21
pubmed: 22044841
Insights Imaging. 2014 Aug;5(4):419-40
pubmed: 25005774
J Magn Reson Imaging. 2011 Mar;33(3):676-83
pubmed: 21563252
AJR Am J Roentgenol. 1998 Jan;170(1):71-7
pubmed: 9423603
J Bone Joint Surg Br. 2000 Aug;82(6):837-41
pubmed: 10990307
Radiology. 1988 Jun;167(3):757-60
pubmed: 3363136
J Bone Joint Surg Br. 1994 Nov;76(6):993-4
pubmed: 7983140
Skeletal Radiol. 2004 Oct;33(10):575-81
pubmed: 15249985

Auteurs

Tobias Geith (T)

Department of Interventional Radiology, Rechts der Isar Hospital, Technical University of Munich, Munich, Germany.

Ann-Cathrin Stellwag (AC)

Department of Radiology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.

Peter E Müller (P)

Department of Orthopedic Surgery, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.

Maximilian Reiser (M)

Department of Radiology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.

Andrea Baur-Melnyk (A)

Department of Radiology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH